| 000 | 01727cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030725.0 | ||
| 008 | 121212s2012 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.24.M.Sc.2012.Za.I | ||
| 100 | 0 | _aZaid Ali Hassan Alsharafi | |
| 245 | 1 | 0 |
_aIntravitreal implants for treatment of posterior segment diseases / _cZaid Ali Hassan Alsharafi ; Supervised Karim Adly Raafat , Mohammed Abdelmonaem Hassaballah , Nahla Borhan Abuhussein |
| 246 | 1 | 5 | _aالزراعات داخل الجسم الزجاجي لعلاج امراض الجزء الخلفي من العين |
| 260 |
_aCairo : _bZaid Ali Hassan Alsharafi , _c2012 |
||
| 300 |
_a87 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Ophthalmology | ||
| 520 | _aAln the ongoing armamentarium against sight threatening diseases not only the drug composition is a determining factor but also the way of delivery is a crucial point to consider. Novel methods of ophthalmic drug delivery are being developed to facilitate treatment of a variety of eye diseases. In order to develop novel methods of ophthalmic drug delivery certain aspects should be considered | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCerium oxide | |
| 653 | 4 | _aCytomegalo virus | |
| 653 | 4 | _aInner oBRB | |
| 700 | 0 |
_aKarim Adly Raafat , _eSupervisor |
|
| 700 | 0 |
_aMohammed Abdelmonaem Hassaballah , _eSupervisor |
|
| 700 | 0 |
_aNahla Borhan Abuhussein , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40580 _d40580 |
||